TherapeuticsMD Inc (TXMD.OQ)
Get access to over 18 million research reports from over 1,700 sources.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
- private equity
- third-party document and information retrieval
- and much, much more…
|75||2012||Independent Chairman of the Board|
|54||2011||President, Secretary, Director|
|46||2012||Chief Executive Officer, Director|
|59||2015||Chief Financial Officer, Treasurer|
|51||2011||Executive Vice President, Chief Strategy Officer|
- BRIEF-TherapeuticsMD Q4 Loss Per Share $0.10
- BRIEF-TherapeuticsMD Submits New Drug Application For TX-001HR
- BRIEF-Therapeuticsmd Announces FDA Acceptance Of New Drug Application And PDUFA Date For TX-004HR
- BRIEF-TherapeuticsMD Announces Resubmission Of New Drug Application For TX-004HR
- BRIEF-TherapeuticsMD reports Q3 loss per share of $0.07